Form 4: Broadwood Partners Boosts STAA Stake

Broadwood Partners, a 10% owner and director, significantly increased its beneficial ownership in STAAR Surgical Co. through multiple open market purchases.

Summary

• Broadwood Partners, L.P., Broadwood Capital, Inc., and Neal C. Bradsher, identified as a 10% owner and director of STAAR Surgical Co. (STAA), reported multiple purchases of common stock.
• On January 6, 2026, Broadwood Partners purchased 186,946 shares of Common Stock at a weighted average price of $21.0111 per share.
• Also on January 6, 2026, an additional 150,000 shares of Common Stock were purchased at a weighted average price of $22.3756 per share.
• On January 7, 2026, 66,467 shares of Common Stock were acquired at a weighted average price of $22.0004 per share.
• On January 8, 2026, 3,240 shares of Common Stock were purchased at a weighted average price of $21.9389 per share.
• Following these transactions, Broadwood Partners' direct beneficial ownership increased to 15,426,144 shares.
• Neal C. Bradsher directly owns 25,900 shares.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 8

Explanation: The significant insider buying by a major shareholder and director, Broadwood Partners, L.P., across multiple transactions and at varying price points, signals strong confidence in STAAR Surgical Co.'s future. This is generally viewed as a very positive indicator by the market.

Positives

• Significant insider buying by a 10% owner and director, Broadwood Partners, indicates strong confidence in STAAR Surgical Co.'s future prospects.
• The purchases were made at varying price points, suggesting a strategic accumulation of shares.
• The use of a Rule 10b5-1(c) plan indicates pre-planned, systematic buying.

Future Outlook

NA

Industry Context

Insider buying by a significant shareholder and director can signal strong internal conviction in the company's strategic direction and operational performance, potentially differentiating it from competitors in the ophthalmic surgical device market.

Stakeholder Impact

• Shareholders may view this insider buying as a positive signal, potentially increasing investor confidence and demand for the stock.
• Employees and customers might perceive this as a sign of stability and strong leadership, reinforcing trust in the company's long-term viability.

Key Dates

Recommendation

The substantial and consistent open market purchases by a 10% owner and director, Broadwood Partners, L.P., at various price levels, strongly suggest deep conviction in STAAR Surgical Co.'s intrinsic value and future growth trajectory. Such significant insider accumulation, especially from a sophisticated institutional investor, often precedes positive operational or strategic developments, making the stock a compelling 'strong buy' for investors seeking long-term value.

Keywords

STAAR Surgical, STAA, Broadwood Partners, Insider Buying, Form 4, Equity Purchase, 10% Owner, Director, Stock Acquisition, Rule 10b5-1